Danisco has invested EUR600m (US$847m) in the company in a bid to add more than 2,000 tonnes to its existing cultures production capacity in the next three years.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Danish food ingredients company said today (18 August) that the investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce its leading market position as a cultures supplier.


The additional capacities will be located both in North America, where Danisco is transforming a former enzyme production unit from its Genencor Division into a cultures plant, and in Europe.


“We will accelerate our time-to-market to better serve our DVI customers using our production hubs in Europe and in the US,” said Doug Willrett, executive vice president, Danisco cultures division.


The company said it has already “debottlenecked” its capacity at several cultures production sites within the past year. The around 2,000 tonnes additional capacity is expected to progressively be commissioned over the next three years and will benefit from the latest process improvements developed by Danisco.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Rochester’s transformation into a cultures plant will enable us to save on time and capital expenditures and be ready in the US during the course of 2009,” said Willrett.


“This is a significant investment from Danisco, which demonstrates the group’s long term commitment to be our customers’ first choice for their needs in state-of-the-art, affordable cultures,” added Fabienne Saadane-Oaks, Danisco bio actives president.